fosamprenavir has been researched along with mefenamic acid in 1 studies
Studies (fosamprenavir) | Trials (fosamprenavir) | Recent Studies (post-2010) (fosamprenavir) | Studies (mefenamic acid) | Trials (mefenamic acid) | Recent Studies (post-2010) (mefenamic acid) |
---|---|---|---|---|---|
174 | 55 | 37 | 1,180 | 158 | 267 |
Protein | Taxonomy | fosamprenavir (IC50) | mefenamic acid (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 1.6 | |
Myeloperoxidase | Homo sapiens (human) | 1.595 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.116 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 1.751 | |
Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 0.56 | |
Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 6.97 | |
Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 3.91 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for fosamprenavir and mefenamic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |